BUDAPEST, HUNGARY and LONDON and PRINCETON, NJ--(Marketwire - November 12, 2009) - ThalesNano,
the world leader in bench top flow chemistry reactor development and
related chemistry services, announced today a strategic alliance with
NanGenex, a nanoformulation technology company. Through this partnership
ThalesNano will immediately begin offering a full range of services from
chemical synthesis of compounds to nanosized formulation.
ThalesNano is internationally recognized for offering customers a wide
range of specialized chemical services using its state of the art flow
reactors. These services include custom synthesis and scale up of difficult
or hazardous reactions, automated catalyst screening, library production,
and custom instrument development. ThalesNano's deep chemistry and
engineering experience coupled with the wide parameter and scale range of
their flow reactors means that ThalesNano can provide novel chemistries,
fast optimization, and cost and time effective solutions to many industry
problems. In addition to these strengths, ThalesNano is now able to
deliver nanoformulated compounds: The NanoActive™ technology from
NanGenex eliminates the key issues of low solubility and permeability often
faced by otherwise promising API candidates.
The NanoActive™ technology overcomes the failures and shortcomings of
the commercially available top-down milling and high pressure
homogenization based technologies and the properties of the produced
nanoparticles can be modified during the synthesis process by the precise
control and optimization of various reaction parameters (e.g. pressure,
temperature, flow rate, pH and concentration). This can reduce the time it
takes to formulate nano-structured active molecules by as much as 90%.
"This new technology further broadens the scope of ThalesNano's service
portfolio," said Dr. Laszlo Urge, CEO of ThalesNano Inc. "Our customers
will benefit significantly from the opportunity to use these integrated and
"We are very happy to work with ThalesNano and make nanoformulation a
natural choice to create active molecules with superior characteristics,"
Gabor Heltovics, CEO of NanGenex said. "This partnership creates an
unparalleled critical mass of flow chemistry and nanoformulation and
delivers great value to our customers."
About ThalesNano Inc.
ThalesNano is the world leader in bench-top flow chemistry reactors. The
company has the widest portfolio of continuous process instruments for the
pharmaceutical, biotech, fine chemical, petroleum/biofuel and education
markets. Its R&D 100 award winning H-Cube® and scale-up system H-Cube
Midi™ are used in hundreds of laboratories globally and have become the
new industry standard for hydrogenation. Within three years from the
original introduction of its flagship H-Cube product, 20 out of the top 20
pharmaceutical companies have introduced and adopted the technology.
More information about ThalesNano can be found at www.thalesnano.com
About NanGenex Inc.
NanGenex is a Proprietary NanoSolution Technology Platform company based
and anchored as a member of the oldest and largest technology corporation
network in Hungary which was established more than 25 years ago. It
provides breakthrough solutions to develop new generations of
NanoActive™ products with significant performance benefits over
conventional approaches. The company has a unique platform of proprietary
technology solutions encompassing the full R&D and commercialization value
chain from upstream research and discovery to full scale product
manufacturing and commercialization.
More information about NanGenex can be found at www.nangenex.com